“Protein biomarkers in plasma: revealing biological insights into tumor microenvironment“
Speakers: Genevieve Boland, Associate Professor of Surgery at Harvard Medical School & Arnav Mehta, Postdoctoral researcher in Immunology at the Broad Institute of MIT and Harvard
The following webinar delves into ICB treatment response, and how protein biomarkers may be used to predict patient responders and non-responders to the therapy.
- Gain an understanding of how to analyze large proteomic datasets and the possible limitations involved.
- Learn how plasma proteomics can be used for monitoring the immune response following immune checkpoint blockade therapy.
- See how plasma proteomics are used to gain insights into biological pathways underlying response and non-response to immune checkpoint blockade.